Arkansas PBM Law Faces Uncertain Future After Judicial Setback: What’s Next?

LITTLE ROCK, Ark. — Arkansas is facing a significant legal crossroads regarding its recently enacted legislation aimed at regulating pharmacy benefit managers (PBMs), companies that manage prescription drug benefits for health plans. A state judge has expressed strong skepticism regarding the law, adding uncertainty to its future and the implications for patient care and drug pricing in the state. The law, which came into effect in 2023, intends to increase transparency and accountability among PBMs. Proponents argue that it would lead to lower drug costs for consumers and improved access to essential medications. However, this … Read more

Wisconsin Family’s Legal Battle Against Pharmacy Chain and PBM Advances in Court

MADISON, Wis. — A federal lawsuit filed by a Wisconsin family against a national pharmacy chain and a pharmacy benefits manager (PBM) will move forward, following a recent court ruling. The family alleges that their daughter’s needs for medication were mishandled, resulting in severe consequences. The case revolves around the family’s claims that the pharmacy and PBM failed to provide sufficient care and support in managing their daughter’s prescription. Central to their complaint is the assertion that errors by these companies compromised her health, raising concerns about accountability in the pharmaceutical industry. Attorneys representing the … Read more

"Spring 2025 PBM Policy Update: Transparency Initiatives and State-Level Action Redefine the Landscape"

Washington, D.C. – Podcast host Bridgette Keller and policy associate David Gilboa recently discussed crucial developments in the Pharmacy Benefit Manager (PBM) sector during the Spring 2025 PBM Policy and Legislative Update. Their conversation highlighted key federal and state legislative activities that are influencing the operational landscape for PBMs this season. Among the most significant federal proposals is the Pharmacy Benefit Manager Transparency Act of 2025, which aims to eliminate spread pricing and mandates full disclosure of rebates and fees between PBMs and stakeholders. Alongside it, the Prescription Pricing for the People Act is calling … Read more